{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T20:14:29Z","timestamp":1789330469638,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T00:00:00Z","timestamp":1706572800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lipidjournal.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jacl.2023.11.010","type":"journal-article","created":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T22:37:42Z","timestamp":1700779062000},"page":"e230-e237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Genetic risk score in patients with the APOE2\/E2 genotype as a predictor of familial dysbetalipoproteinemia"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6068-4948","authenticated-orcid":false,"given":"Martin","family":"Satny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6847-6687","authenticated-orcid":false,"given":"Veronika","family":"Todorovova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tereza","family":"Altschmiedova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslav A.","family":"Hubacek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Dlouha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Lanska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Soska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ondrej","family":"Kyselak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6532-7053","authenticated-orcid":false,"given":"Tomas","family":"Freiberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bobak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7226-1926","authenticated-orcid":false,"given":"Michal","family":"Vrablik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2023.11.010_bib0001","unstructured":"Deaths 2020. Prague: agency for medical informations and statistics Czech Republic 2021. https:\/\/www.czso.cz\/csu\/czso\/demograficka-rocenka-ceske-republiky-2020."},{"issue":"9438","key":"10.1016\/j.jacl.2023.11.010_bib0002","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.jacl.2023.11.010_bib0003","doi-asserted-by":"crossref","first-page":"4182","DOI":"10.3390\/ijms22084182","article-title":"Genetics of cardiovascular disease: how far are we from personalized CVD risk prediction and management?","volume":"22","author":"Vrablik","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jacl.2023.11.010_bib0004","doi-asserted-by":"crossref","first-page":"471","DOI":"10.7326\/0003-4819-75-3-471","article-title":"An international classification of hyperlipidemias and hyperlipoproteinemias","volume":"75","author":"Fredrickson","year":"1971","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.jacl.2023.11.010_bib0005","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.atherosclerosis.2015.02.046","article-title":"Vascular risk factors, vascular disease, lipids and lipid targets in patients with familial dysbetalipoproteinemia: a European cross-sectional study","volume":"240","author":"Koopal","year":"2015","journal-title":"Atherosclerosis"},{"issue":"9","key":"10.1016\/j.jacl.2023.11.010_bib0006","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s11883-014-0440-2","article-title":"Hyperlipoproteinemia type 3: the forgotten phenotype","volume":"16","author":"Hopkins","year":"2014","journal-title":"Curr Atheroscler Rep"},{"issue":"4","key":"10.1016\/j.jacl.2023.11.010_bib0007","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jacl.2007.07.006","article-title":"Diagnosis of type III hyperlipoproteinemia from plasma total cholesterol, triglyceride, and apolipoprotein B","volume":"1","author":"Sniderman","year":"2007","journal-title":"J Clin Lipidol"},{"issue":"4","key":"10.1016\/j.jacl.2023.11.010_bib0008","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.jacl.2020.06.004","article-title":"A simplified diagnosis algorithm for dysbetalipoproteinemia","volume":"14","author":"Paquette","year":"2020","journal-title":"J Clin Lipidol"},{"issue":"1","key":"10.1016\/j.jacl.2023.11.010_bib0009","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jacl.2016.10.001","article-title":"Autosomal dominant familial dysbetalipoproteinemia: a pathophysiological framework and practical approach to diagnosis and therapy","volume":"11","author":"Koopal","year":"2017","journal-title":"J Clin Lipidol"},{"issue":"1","key":"10.1016\/j.jacl.2023.11.010_bib0010","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1210\/clinem\/dgac503","article-title":"Dysbetalipoproteinemia is associated with increased risk of coronary and peripheral vascular disease","volume":"108","author":"Paquette","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.jacl.2023.11.010_bib0011","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0021-9150(94)05402-5","article-title":"Arginine residues at codons 112 and 158 in the apolipoprotein E gene correspond to the ancestral state in humans","volume":"112","author":"Hanlon","year":"1995","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.jacl.2023.11.010_bib0012","first-page":"112","article-title":"Patterns of dyslipoproteinemia in selected North American populations. The Lipid Research Clinics Program Prevalence Study","volume":"73","author":"LaRosa","year":"1986","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.jacl.2023.11.010_bib0013","doi-asserted-by":"crossref","first-page":"993","DOI":"10.5114\/aoms.2019.86972","article-title":"Modern prevalence of dysbetalipoproteinemia (Fredrickson-Levy-Lees type III hyperlipoproteinemia)","volume":"16","author":"Pallazola","year":"2020","journal-title":"Arch Med Sci"},{"issue":"4","key":"10.1016\/j.jacl.2023.11.010_bib0014","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1399-0004.2005.00510.x","article-title":"Polymorphisms in the apolipoprotein A5 (APOA5) gene and type III hyperlipidemia","volume":"68","author":"Evans","year":"2005","journal-title":"Clin Genet"},{"key":"10.1016\/j.jacl.2023.11.010_bib0015","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1471-2350-8-56","article-title":"The D9N, N291S and S447X variants in the lipoprotein lipase (LPL) gene are not associated with Type III hyperlipidemia","volume":"8","author":"Evans","year":"2007","journal-title":"BMC Med Genet"},{"issue":"4","key":"10.1016\/j.jacl.2023.11.010_bib0016","doi-asserted-by":"crossref","first-page":"371","DOI":"10.12998\/wjcc.v3.i4.371","article-title":"Two cases report and a diagnostic algorithm","volume":"3","author":"Kei","year":"2015","journal-title":"World J Clin Cases"},{"issue":"5","key":"10.1016\/j.jacl.2023.11.010_bib0017","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/ejhg.2008.202","article-title":"The expression of type III hyperlipoproteinemia: involvement of lipolysis genes","volume":"17","author":"Henneman","year":"2009","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"10.1016\/j.jacl.2023.11.010_bib0018","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13073-020-00742-5","article-title":"Polygenic risk scores: from research tools to clinical instruments","volume":"12","author":"Lewis","year":"2020","journal-title":"Genome Med"},{"key":"10.1016\/j.jacl.2023.11.010_bib0019","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3389\/fendo.2020.00455","article-title":"Genetics of hypertriglyceridemia","volume":"11","author":"Dron","year":"2020","journal-title":"Front Endocrinol"},{"issue":"8","key":"10.1016\/j.jacl.2023.11.010_bib0020","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11883-021-00939-y","article-title":"The genetic basis of hypertriglyceridemia","volume":"23","author":"Carrasquilla","year":"2021","journal-title":"Curr Atheroscler Rep"},{"issue":"7307","key":"10.1016\/j.jacl.2023.11.010_bib0021","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nature09270","article-title":"Biological, clinical and population relevance of 95 loci for blood lipids","volume":"466","author":"Teslovich","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jacl.2023.11.010_bib0022","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1161\/ATVBAHA.111.226365","article-title":"An increased burden of common and rare lipid-associated risk alleles contributes to the phenotypic spectrum of hypertriglyceridemia","volume":"31","author":"Johansen","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"10.1016\/j.jacl.2023.11.010_bib0023","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s40291-019-00412-2","article-title":"The gene score for predicting hypertriglyceridemia: new insights from a Czech case\u2013control study","volume":"23","author":"Hubacek","year":"2019","journal-title":"Mol Diagn Ther"},{"issue":"2","key":"10.1016\/j.jacl.2023.11.010_bib0024","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.atherosclerosis.2010.04.007","article-title":"Longitudinal trends in major cardiovascular risk factors in the Czech population between 1985 and 2007\/8. Czech MONICA and Czech post-MONICA","volume":"211","author":"Cifkova","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2023.11.010_bib0025","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/1471-2458-6-255","article-title":"Determinants of cardiovascular disease and other non-communicable diseases in Central and Eastern Europe: rationale and design of the HAPIEE study","volume":"6","author":"Peasey","year":"2006","journal-title":"BMC Public Health"},{"issue":"9\u201310","key":"10.1016\/j.jacl.2023.11.010_bib0026","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1007\/s10528-009-9266-y","article-title":"Apolipoprotein E polymorphism in hemodialyzed patients and healthy controls","volume":"47","author":"Hubacek","year":"2009","journal-title":"Biochem Genet"},{"issue":"8","key":"10.1016\/j.jacl.2023.11.010_bib0027","doi-asserted-by":"crossref","first-page":"5873","DOI":"10.1007\/s11033-021-06581-w","article-title":"The APOE4 allele is associated with a decreased risk of retinopathy in type 2 diabetics","volume":"48","author":"Dlouha","year":"2021","journal-title":"Mol Biol Rep"},{"issue":"3","key":"10.1016\/j.jacl.2023.11.010_bib0028","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","article-title":"A simple salting out procedure for extracting DNA from human nucleated cells","volume":"16","author":"Miller","year":"1988","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"10.1016\/j.jacl.2023.11.010_bib0029","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0022-2275(20)43176-1","article-title":"Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI","volume":"31","author":"Hixson","year":"1990","journal-title":"J Lipid Res"},{"issue":"5540","key":"10.1016\/j.jacl.2023.11.010_bib0030","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1126\/science.1064852","article-title":"An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing","volume":"294","author":"Pennacchio","year":"2001","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.jacl.2023.11.010_bib0031","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101082","article-title":"Rs964184 (APOA5-A4-C3-A1) is related to elevated plasma triglyceride levels, but not to an increased risk for vascular events in patients with clinically manifest vascular disease","volume":"9","author":"Van De Woestijne","year":"2014","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.jacl.2023.11.010_bib0032","doi-asserted-by":"crossref","first-page":"e37056","DOI":"10.1371\/journal.pone.0037056","article-title":"A replication study of GWAS-derived lipid genes in Asian Indians: the chromosomal region 11q23.3 harbors loci contributing to triglycerides","volume":"7","author":"Braun","year":"2012","journal-title":"PLoS ONE"},{"issue":"9726","key":"10.1016\/j.jacl.2023.11.010_bib0033","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/S0140-6736(10)60545-4","article-title":"Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies","volume":"375","author":"Sarwar","year":"2010","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jacl.2023.11.010_bib0034","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/ng.291","article-title":"Common variants at 30 loci contribute to polygenic dyslipidemia","volume":"41","author":"Kathiresan","year":"2009","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.jacl.2023.11.010_bib0035","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1194\/jlr.R009720","article-title":"Genetic determinants of plasma triglycerides","volume":"52","author":"Johansen","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jacl.2023.11.010_bib0036","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/ng.2007.61","article-title":"Genome-wide scan identifies variation in MLXIPL associated with plasma triglycerides","volume":"40","author":"Kooner","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacl.2023.11.010_bib0037","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ng.76","article-title":"Newly identified loci that influence lipid concentrations and risk of coronary artery disease","volume":"40","author":"Willer","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacl.2023.11.010_bib0038","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00439-008-0577-6","article-title":"MLXIPL variant in individuals with low and high triglyceridemia in white population in Central Europe","volume":"124","author":"Vrablik","year":"2008","journal-title":"Hum Genet"},{"key":"10.1016\/j.jacl.2023.11.010_bib0039","article-title":"The transferability of lipid loci across African, Asian and European cohorts","volume":"1","author":"Kuchenbaecker","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jacl.2023.11.010_bib0040","doi-asserted-by":"crossref","first-page":"101","DOI":"10.33549\/physiolres.933580","article-title":"Polygenic hypercholesterolemia: examples of GWAS results and their replication in the Czech-Slavonic population","volume":"66","author":"Hubacek","year":"2017","journal-title":"Physiol Res"},{"issue":"20","key":"10.1016\/j.jacl.2023.11.010_bib0041","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1161\/CIRCULATIONAHA.121.057642","article-title":"Associations of dietary cholesterol, serum cholesterol, and egg consumption with overall and cause-specific mortality: systematic review and updated meta-analysis","volume":"145","author":"Zhao","year":"2022","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.jacl.2023.11.010_bib0042","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1016\/j.numecd.2021.03.003","article-title":"Association of BMI with cardiovascular disease incidence and mortality in patients with type 2 diabetes mellitus: a systematic review and dose-response meta-analysis of cohort studies","volume":"31","author":"Zhao","year":"2021","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"R2","key":"10.1016\/j.jacl.2023.11.010_bib0043","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/hmg\/ddz205","article-title":"Validity of polygenic risk scores: are we measuring what we think we are?","volume":"28","author":"Janssens","year":"2019","journal-title":"Hum Mol Genet"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287423003422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287423003422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T01:08:46Z","timestamp":1729213726000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287423003422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1933287423003422"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2023.11.010","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic risk score in patients with the APOE2\/E2 genotype as a predictor of familial dysbetalipoproteinemia","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2023.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of National Lipid Association.","name":"copyright","label":"Copyright"}]}}